Related Experiment Videos
[Cranial computed tomography in maple syrup urine disease]
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|April 1, 1986
Summary
Early diagnosis of maple syrup urine disease (MSUD) is crucial. Cranial CT scans in MSUD show reversible brain changes with prompt protein-restricted diets, preventing irreversible atrophy.
Area of Science:
- Neurology
- Metabolic Disorders
- Pediatric Imaging
Background:
- Maple syrup urine disease (MSUD) is a rare inherited metabolic disorder.
- It is characterized by the inability to metabolize branched-chain amino acids.
- The intermediate phenotype presents unique diagnostic challenges.
Observation:
- Cranial computed tomography (CT) in early-stage intermediate MSUD reveals diffuse, symmetric white and grey matter hypodensities.
- These abnormalities normalize with early dietary protein restriction.
- Delayed diagnosis leads to progressive global cerebral atrophy over years.
Findings:
- CT hypodensity correlates with cerebral lipid and water content, impacting myelination.
- The severity of pathological changes, detectable histologically but not by CT, relates to atrophy progression.
- Morphological parameters correlate with clinical outcomes and treatment success.
Implications:
- Early CT imaging can guide diagnosis and monitor treatment response in MSUD.
- Prompt dietary intervention is key to preventing long-term neurological damage.
- Histological examination may be necessary for assessing severe pathological changes not visible on CT.